Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

European Medicines Agency
News & Press Releases
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 May 2021 (new)
PRAC, Last updated: 07/05/2021

News: EMA starts rolling review of sotrovimab (VIR-7831) for COVID-19 (new)
CHMP, Last updated: 07/05/2021

News: International regulators and WHO call for wider public access to clinical data (new)
Last updated: 07/05/2021

News: Confidentiality arrangement between EU and Brazilian regulatory authorities (new)
Last updated: 06/05/2021

News: EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated (new)
CHMP, Last updated: 04/05/2021

News: EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15 (new)
CHMP, Last updated: 03/05/2021

 

European Commission
https://ec.europa.eu/commission/presscorner/home/en
News 8 May 2021
“The EU stands with India in times of need”: op-ed article by Ursula von der Leyen, President of the European Commission
“As soon as India requested support, the EU and its member states came together to help. We activated our EU civil protection mechanism in one of its biggest-ever response operations. This is what friends do in times of need.”

Press release 6 May 2021
Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics
The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’.